Status:
COMPLETED
EEG Biomarkers for Predicting Response to Antidepressant Therapy
Lead Sponsor:
Medtronic - MITG
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
21-75 years
Brief Summary
The purpose of this study is to evaluate the potential early EEG predictors of an individual's response to treatment with antidepressant medications. Objectives: * Prospectively confirm accuracy of ...
Detailed Description
According to recent clinical studies sponsored by the NIH, fewer than half of subjects diagnosed with a major depressive episode respond to the first trial of an antidepressant medication. While the m...
Eligibility Criteria
Inclusion
- Subject has diagnosis of Major Depressive Disorder
Exclusion
- Subject is suffering from cognitive, bipolar, or psychotic disorder
- Subject has had a course of ECT within the past six months
- Subject has any known contraindication for use of any of the study drugs
- Subject has a known drug dependency or substance abuse within the past six mon ths
- Subject is currently pregnant or not using a medically acceptable means of birth control
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
375 Patients enrolled
Trial Details
Trial ID
NCT00289523
Start Date
January 1 2006
End Date
July 1 2007
Last Update
March 7 2012
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Los Angeles-Westwood
Los Angeles, California, United States, 90024
2
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048
3
University of California, San Diego
San Diego, California, United States, 92161
4
University of California, Los Angeles-Harbor
Torrance, California, United States, 90509